Literature DB >> 10689107

Origins of the first HLA specificities.

I Park1, P Terasaki.   

Abstract

Following the discovery of the first histocompatibility antigen "MAC" in 1958, numerous independent laboratories began identifying HLA specificities with allo-antibodies. During the span of about a decade, 1958-1970, virtually all of the common HLA-A and HLA-B antigens were identified by various names and presented at the International Histocompatibility Workshops by means of different serological methods. Because many of the independently discovered specificities were found to be reactive to similar determinants on lymphocytes, it became necessary to classify the antigens by means of a standard method. The micro lymphocytotoxicity test was chosen to be the basis for future antigen testing, thereby allowing the various laboratories to confidently exchange sera. At the 1968 WHO Nomenclature meeting, the naming of the first antigen ultimately gave rise to the designation "HLA" in the human MHC Class I antigen system. This paper looks back upon the origins of the early serologically identified HLA specificities and their respective founders.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10689107     DOI: 10.1016/s0198-8859(99)00154-8

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  3 in total

Review 1.  Approaching Genetics Through the MHC Lens: Tools and Methods for HLA Research.

Authors:  Venceslas Douillard; Erick C Castelli; Steven J Mack; Jill A Hollenbach; Pierre-Antoine Gourraud; Nicolas Vince; Sophie Limou
Journal:  Front Genet       Date:  2021-12-02       Impact factor: 4.599

2.  HLA typing from RNA-seq data using hierarchical read weighting [corrected].

Authors:  Hyunsung John Kim; Nader Pourmand
Journal:  PLoS One       Date:  2013-06-28       Impact factor: 3.240

Review 3.  Does HLA matching matter in the modern era of renal transplantation?

Authors:  Jon Jin Kim; Susan V Fuggle; Stephen D Marks
Journal:  Pediatr Nephrol       Date:  2019-12-09       Impact factor: 3.714

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.